Journal of Biological ChemistryCell BiologyPeer-reviewed journal article
The zinc metalloprotease ZMPSTE24 binds a distinct topological isoform of the tail-anchored protein IFITM3
Eric D. SpeariD, Khurts ShilagardiiD, Sonia SarjuiD, Susan MichaelisiD
Abstract
The biogenesis of integral membrane proteins is complex, as revealed by an ever-growing number of cellular components shown to be dedicated to the insertion, folding, surveillance, rectification, or quality control of specific client membrane proteins. The zinc metalloprotease ZMPSTE24 and its yeast homolog Ste24 have well-established roles in the proteolytic maturation of the nuclear scaffold protein lamin A and yeast a-factor, respectively. Additionally, Ste24 has been implicated through yeast genetic screens in a variety of membrane processes, including ER- associated degradation (ERAD), Sec61 translocon "unclogging," the unfolded protein response (UPR), and potentially as a membrane protein topology determinant. Recently, an interaction was demonstrated between ZMPSTE24 and the antiviral interferon induced transmembrane protein IFITM3, although the functional significance of this interaction is not well-understood. IFITM3 is a tail-anchored protein with a cytoplasmic N-terminus, a single transmembrane span, and a lumenal/exocellular C-terminus. Here, we show that a catalytic-dead version of ZMPSTE24, ZMPSTE24E336A, exhibits enhanced binding to IFITM3, and this bound species of IFITM3 is hypo-palmitoylated. Using a split fluorescence topology reporter, we demonstrate that ZMPSTE24E336A "traps" and stabilizes a subpopulation of IFITM3 molecules with an atypical membrane topology, whose C-terminus is cytosolic instead of lumenal. Such inverted forms of IFITM3 are also detected in the presence of ERAD inhibitors when ZMPSTE24E336A is absent. We hypothesize the ZMPSTE24E336A trap mutant reveals a normally transient isoform of IFITM3 whose transmembrane span is inverted and that ZMPSTE24 is involved in the quality control of IFITM3 topology, either inverting, correcting or assisting in removal of aberrant IFITM3 molecules.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 43%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Defining Substrate Requirements for Cleavage of Farnesylated Prelamin A by the Integral Membrane Zinc Metalloprotease ZMPSTE24
K. M. Wood, E. D. Spear, … S. Michaelis·bioRxiv·Sep 2, 2020
- Cleavage Site Specificity for Processing of Farnesylated Prelamin A by the Zinc Metalloprotease ZMPSTE24
T. D. Babatz, E. D. Spear, … S. Michaelis·bioRxiv·Aug 17, 2020
- SNARE mimicry by the CD225 domain of IFITM3 enables regulation of homotypic late endosome fusion
Kazi Rahman, Isaiah Wilt, … Alex A. Compton·The EMBO JournalPeer-reviewed·Dec 9, 2024
- ZMPSTE24 Missense Mutations that Cause Progeroid Diseases Decrease Prelamin A Cleavage Activity and/or Protein Stability
E. Spear, E.-T. Hsu, … S. Michaelis·bioRxiv·May 21, 2018
- Attenuation of IFITM proteins antiviral activity through sequestration into intraluminal vesicles of late endosomes
David Přikryl, You Zhang, … Gregory B. Melikyan·Frontiers in ImmunologyPeer-reviewed·Aug 21, 2025
- Cholesterol binds the amphipathic helix of IFITM3 and regulates antiviral activity
K. Rahman, S. A. K. Datta, … A. A. Compton·bioRxiv·Apr 21, 2022